Cargando…

Treatment of recurrent epithelial ovarian cancer

Epidemiologic analysis reveals that the mortality rate from ovarian cancer is continuously decreasing due to the improvement of surgery and chemotherapy. However, the prognosis of ovarian cancer patients is still unsatisfactory overall considering that only 30% of patients are alive after five years...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pisano, Carmela, Bruni, Giovanni S, Facchini, Gaetano, Marchetti, Claudia, Pignata, Sandro
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2009
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695243/ https://www.ncbi.nlm.nih.gov/pubmed/19753136

Ejemplares similares

Clinical Trials with Pegylated Liposomal Doxorubicin in the Treatment of Ovarian Cancer
por: Pisano, Carmela, et al.
Publicado: (2013)

Ovarian cancer standard of care: are there real alternatives?
por: Pepa, Chiara Della, et al.
Publicado: (2015)

Detection of high mobility group A2 specific mRNA in the plasma of patients affected by epithelial ovarian cancer
por: Galdiero, Francesca, et al.
Publicado: (2015)

Treatment of Recurrent Epithelial Ovarian Cancer
por: Claussen, Carlota, et al.
Publicado: (2020)

The role of pemetrexed in recurrent epithelial ovarian cancer: A scoping review
por: Roche, Michael, et al.
Publicado: (2018)

Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study
por: Farolfi, Alberto, et al.
Publicado: (2020)

A miRNA signature assessing ovarian cancer prognosis
por: Bagnoli, Marina, et al.
Publicado: (2016)

Update on the secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: a narrative review
por: Conte, Carmine, et al.
Publicado: (2021)

Palliative systemic therapy for women with recurrent epithelial ovarian cancer: current options
por: Elit, Laurie, et al.
Publicado: (2013)

Microsatellite Instability: From the Implementation of the Detection to a Prognostic and Predictive Role in Cancers
por: Amato, Martina, et al.
Publicado: (2022)

The detection, treatment, and biology of epithelial ovarian cancer
por: Gubbels, Jennifer AA, et al.
Publicado: (2010)

First-line treatment of women with advanced ovarian cancer: focus on bevacizumab
por: Marchetti, Claudia, et al.
Publicado: (2019)

Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study
por: Pignata, Sandro, et al.
Publicado: (2006)

Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review
por: Marchetti, Claudia, et al.
Publicado: (2014)

Relationship between ovarian cancer stem cells, epithelial mesenchymal transition and tumour recurrence
por: Padilla, Monica Angelica Amaya, et al.
Publicado: (2019)

Nivolumab–ipilimumab in renal cell carcinoma metastatic to the bones: A case report
por: Di Napoli, Marilena, et al.
Publicado: (2022)

Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer
por: Chen, Wei-Chun, et al.
Publicado: (2022)

Medical treatment of early stage and rare histological variants of epithelial ovarian cancer
por: Cont, Nicoletta Tomasi, et al.
Publicado: (2015)

Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy
por: Macpherson, Anne M., et al.
Publicado: (2020)

Treatment Strategy for Recurrent and Refractory Epithelial Ovarian Cancer: Efficacy of High-Dose Chemotherapy with Hematopoietic Stem Cell Transplantation
por: Muramatsu, Toshinari, et al.
Publicado: (2006)

Platelet count as a biomarker for monitoring treatment response and disease recurrence in recurrent epithelial ovarian cancer
por: Hu, Qinghong, et al.
Publicado: (2020)

Treatment for Recurrent Ovarian Cancer—At First Relapse
por: Ushijima, Kimio
Publicado: (2010)

The Role of Intra-Tumoral Heterogeneity and Its Clinical Relevance in Epithelial Ovarian Cancer Recurrence and Metastasis
por: Roberts, Cai M., et al.
Publicado: (2019)

Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives – a review
por: Gupta, Sudeep, et al.
Publicado: (2019)

PARP Inhibitors in Endometrial Cancer: Current Status and Perspectives
por: Musacchio, Lucia, et al.
Publicado: (2020)

Analysis of A Disintegrin and Metalloprotease 17 (ADAM17) Expression as a Prognostic Marker in Ovarian Cancer Patients Undergoing First-Line Treatment Plus Bevacizumab
por: Fabbi, Marina, et al.
Publicado: (2022)

Clinical utility of targeted treatments in the management of epithelial ovarian cancer
por: Twu, Cheryl, et al.
Publicado: (2012)

Profile of pazopanib and its potential in the treatment of epithelial ovarian cancer
por: Davidson, Brittany A, et al.
Publicado: (2014)

Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment
por: Rojas, Veronica, et al.
Publicado: (2016)

Prevalence of Epithelial Ovarian Cancer Stem Cells Correlates with Recurrence in Early-Stage Ovarian Cancer
por: Steffensen, Karina Dahl, et al.
Publicado: (2011)

Hyperthermic Intraperitoneal Chemotherapy (HIPEC): New Approaches and Controversies on the Treatment of Advanced Epithelial Ovarian Cancer—Systematic Review and Meta-Analysis
por: Della Corte, Luigi, et al.
Publicado: (2023)

Afatinib use in recurrent epithelial ovarian carcinoma
por: Shepherd-Littlejohn, Amanda L., et al.
Publicado: (2019)

Minimally-Invasive Secondary Cytoreduction in Recurrent Ovarian Cancer
por: Certelli, Camilla, et al.
Publicado: (2023)

Olaparib in Epithelial Ovarian Cancer
por: Anastasia, Paula J.
Publicado: (2016)

Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors
por: De Giorgi, Ugo, et al.
Publicado: (2019)

Re-treatment with PARPi in patients with recurrent epithelial ovarian cancer: A single institutional experience
por: Moubarak, Malak, et al.
Publicado: (2022)

Therapeutic strategies in epithelial ovarian cancer
por: Kim, Ayako, et al.
Publicado: (2012)

Estrogen, Progesterone and Epithelial Ovarian Cancer
por: Ho, Shuk-Mei
Publicado: (2003)

Chemokine Receptors in Epithelial Ovarian Cancer
por: Muralidhar, Goda G., et al.
Publicado: (2013)

Targeted Therapies in Epithelial Ovarian Cancer
por: Dean, Emma, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_u7dprdrnq50luq1r6lhentbgtg